The Drug Evaluations functionality in Anasalva provides users with an organized and accessible update on the most recent changes to approved drugs. This tool classifies modifications by months and regulatory agencies, including the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency) and AEMPS (Spanish Agency for Medicines and Health Products), ensuring comprehensive and accurate coverage.
Main features of the Drug Evaluations functionality:
- Monthly organization: The information is presented on a month-by-month basis, allowing users to review changes in drug information chronologically, making it easy to keep track of recent updates.
- Update of indications: This section highlights any expansion or restriction in the approved indications of the drugs, informing physicians and users about new therapeutic applications or limitations in the use of each drug.
- Changes in adverse reactions:Anasalva reports any changes in adverse reaction profiles, highlighting newly identified side effects or updates in the frequency or severity of known reactions.
- Other relevant information:Includes dosage modifications, special warnings, contraindications and changes in administration instructions. It also provides information on new restrictions or monitoring requirements that may have been implemented by agencies.
This functionality is a valuable tool for physicians, pharmacists and other healthcare professionals, as well as patients who want to be informed about the medicines they use. By bringing together updates from the major regulatory agencies in one place, Anasalva Drug Evaluations facilitates access to critical information for clinical practice and informed decision making.
EN 
ES